<?xml version="1.0" encoding="UTF-8"?>
<table xmlns="http://www.w3.org/1999/xhtml">
 <caption class="caption">
  <label class="label">Table 2</label>
  <p class="p" xmlns="">Constituents from essential oils tested in experimental depression.</p>
 </caption>
 <thead class="thead">
  <tr class="tr" xmlns="">
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" class="th">Constituents</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" class="th">Via of Administration and Duration of Treatment</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" class="th">Animal Specie</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" class="th">Dose Range Tested and Minimal Active Dose</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" class="th">Behavioral Test</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" class="th">Observed Effects</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" class="th">Mechanism of Action</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" class="th">Observations</th>
   <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1" class="th">Reference</th>
  </tr>
 </thead>
 <tbody class="tbody">
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">
    <inline-graphic xlink:href="molecules-22-01290-i001.jpg" class="inline-graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/>
   </td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Intraperitoneal, acute</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">ICR mouse</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">5–20 mg/kg (10 mg/kg)</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">FST, TST</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Reduced immobility time in both assays</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td"> </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DR+</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[ 
    <xref rid="B33-molecules-22-01290" ref-type="bibr" class="xref">33</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Asarone</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Controls: negative and positive (imipramine)</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td"> </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">
    <inline-graphic xlink:href="molecules-22-01290-i002.jpg" class="inline-graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/>
   </td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Intraperitoneal, acute</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">C57BL/6 mouse</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">50 mg/kg</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">FST, TST, novelty-suppressed feeding behavior</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Reduced immobility time in the TST and the FST; decreased feeding latency in the novelty-suppressed feeding test</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">The pretreatment with AM630 (CB 
    <sub class="sub">2</sub> antagonist) prevented the anti-immobility effects 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DR−</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[ 
    <xref rid="B52-molecules-22-01290" ref-type="bibr" class="xref">52</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">β-Caryophyllene</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Controls: negative</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td"> </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">
    <inline-graphic xlink:href="molecules-22-01290-i003.jpg" class="inline-graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/>
   </td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Oral gavage, acute</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Swiss mouse</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">12.5–50 mg/kg (12.5 mg/kg)</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">FST, TST</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Reduced immobility time in both tests</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">The pretreatment with SCH23390 (D 
    <sub class="sub">1</sub> antagonist) and sulpiride (D 
    <sub class="sub">2</sub> antagonist) prevented the anti-immobility effects 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DR+</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[ 
    <xref rid="B68-molecules-22-01290" ref-type="bibr" class="xref">68</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Carvacrol</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Controls: negative and positive (imipramine)</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td"> </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">
    <inline-graphic xlink:href="molecules-22-01290-i004.jpg" class="inline-graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/>
   </td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Oral gavage, 21 days</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">SD rat, 18 months old</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">22.5–90 mg/kg (45 mg/kg)</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">CUMS</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Reversed decreased sucrose preference and spontaneous locomotion in CUMS rats</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Reversed the increased hippocampal COX-2 protein and activity; Reversed the elevated PGE 
    <sub class="sub">2</sub> concentration in frontal cortex and hippocampus in CUMS rats 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DR+</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[ 
    <xref rid="B69-molecules-22-01290" ref-type="bibr" class="xref">69</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Cinnamic aldehyde</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Controls: negative and positive (fluoxetine)</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td"> </td>
  </tr>
  <tr class="tr" xmlns="">
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">
    <inline-graphic xlink:href="molecules-22-01290-i005.jpg" class="inline-graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/>
   </td>
   <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Inhalation, acute</td>
   <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">SD rats</td>
   <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Saturated chamber (60 min)</td>
   <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">FST</td>
   <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Reduced immobility time</td>
   <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td"> </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DR−</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[ 
    <xref rid="B36-molecules-22-01290" ref-type="bibr" class="xref">36</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Controls: negative and positive (imipramine)</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td"> </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Citral</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Hypolocomotion</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td"> </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">
    <inline-graphic xlink:href="molecules-22-01290-i006.jpg" class="inline-graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/>
   </td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Intraperitoneal, acute</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Wistar rat</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">0.1–0.3 g/kg</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">FST</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">No effects</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td"> </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DR+</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[ 
    <xref rid="B45-molecules-22-01290" ref-type="bibr" class="xref">45</xref>, 
    <xref rid="B70-molecules-22-01290" ref-type="bibr" class="xref">70</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">γ-Decanolactone</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Controls: negative Hypolocomotion at higher doses</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td"> </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">
    <inline-graphic xlink:href="molecules-22-01290-i007.jpg" class="inline-graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/>
   </td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Intraperitoneal, three times within 24 h</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">ICR mouse</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">100 mg/kg</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">FST</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">No effects</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td"> </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DR−</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[ 
    <xref rid="B40-molecules-22-01290" ref-type="bibr" class="xref">40</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Eucalyptol</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Controls: negative and positive (imipramine)</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td"> </td>
  </tr>
  <tr class="tr" xmlns="">
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">
    <inline-graphic xlink:href="molecules-22-01290-i008.jpg" class="inline-graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/>
   </td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Intraperitoneal, 14 days</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">ddY mice</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">10–100 mg/kg (30 mg/kg)</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">FST, TST</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Reduced immobility time in the TST and increased number of wheel rotations in the FST</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Increased Hippocampal BDNF and metallothionein-III (brain-predominant protein that alleviates various neurotoxic events) mRNA</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DR+</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[ 
    <xref rid="B61-molecules-22-01290" ref-type="bibr" class="xref">61</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Controls: negative and positive (imipramine)</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td"> </td>
  </tr>
  <tr class="tr" xmlns="">
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Eugenol</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Oral, mixed with drinking water, 14 days</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">ICR mouse</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">0.17 mmol/kg</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">FST</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Increased number of wheel rotations in the FST</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Inhibits human MAO 
    <sub class="sub">A</sub> (IC50 34.4 µM) preferencially than MAO 
    <sub class="sub">B</sub> (IC 
    <sub class="sub">50</sub> 288 µM) activity 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DR−</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[ 
    <xref rid="B62-molecules-22-01290" ref-type="bibr" class="xref">62</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Controls: negative</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td"> </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">
    <inline-graphic xlink:href="molecules-22-01290-i009.jpg" class="inline-graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/>
   </td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Oral gavage, 4 weeks</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">ICR mouse</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">20–40 mg/kg (20 mg/kg)</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">CUMS, FST, TST</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Restored decreased sucrose preference and increased immobility time in the TST and FST in mice subjected to CUMS</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Reversed the IL-1β-related CNS inflammation by markedly inhibiting CUMS-induced PFC NF-κB pathway and modulating NLRP3 inflammasome activation (activated caspase 1) in CUMS mice</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DR+</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[ 
    <xref rid="B60-molecules-22-01290" ref-type="bibr" class="xref">60</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Geraniol</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Controls: negative and positive (fluoxetine)</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td"> </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">
    <inline-graphic xlink:href="molecules-22-01290-i010.jpg" class="inline-graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/>
   </td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Intraperitoneal, acute</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Swiss mouse</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">25–50 mg/kg (25 mg/kg)</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">FST, TST</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Increased immobility time</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td"> </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DR+</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[ 
    <xref rid="B71-molecules-22-01290" ref-type="bibr" class="xref">71</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Isopulegol</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Controls: negative and positive (imipramine)</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td"> </td>
  </tr>
  <tr class="tr" xmlns="">
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">
    <inline-graphic xlink:href="molecules-22-01290-i011.jpg" class="inline-graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/>
   </td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Oral gavage, 15 days</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Wistar rat</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">10 mg/kg</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">FST</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Restored increased immobility time in rats subjected to a model of neuropathic pain</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td"> </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DR−</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[ 
    <xref rid="B46-molecules-22-01290" ref-type="bibr" class="xref">46</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Controls: negative and positive (ketamine)</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td"> </td>
  </tr>
  <tr class="tr" xmlns="">
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Limonene</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Intraperitoneal, three times within 24 h</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">ICR mouse</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">100 mg/kg</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">FST</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">No effects</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td"> </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DR−</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[ 
    <xref rid="B40-molecules-22-01290" ref-type="bibr" class="xref">40</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Controls: negative and positive (imipramine)</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td"> </td>
  </tr>
  <tr class="tr" xmlns="">
   <td rowspan="8" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">
    <inline-graphic xlink:href="molecules-22-01290-i012.jpg" class="inline-graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/>
    <break class="break"/>Linalool 
   </td>
   <td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Intraperitoneal, three times within 24 h</td>
   <td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">ICR mouse</td>
   <td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">54.8–173.2 mg/kg (100 mg/kg)</td>
   <td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">FST</td>
   <td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Reduced immobility time</td>
   <td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td"> </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DR+</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[ 
    <xref rid="B40-molecules-22-01290" ref-type="bibr" class="xref">40</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">U-inverted curve</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td"> </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Controls: negative and positive (imipramine)</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td"> </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">The treatment reduced spontaneous locomotion</td>
  </tr>
  <tr class="tr" xmlns="">
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Intraperitoneal, three times within 24 h</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">ICR mouse</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">100 mg/kg</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">FST</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Reduced immobility time</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">The pretreatment with WAY100,635 (5-HT 
    <sub class="sub">1A</sub> antagonist) and yohimbine (α 
    <sub class="sub">2</sub>-antagonist) prevented the antidepressant-like effects 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DR−</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">[ 
    <xref rid="B58-molecules-22-01290" ref-type="bibr" class="xref">58</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Controls: negative and positive (imipramine)</td>
  </tr>
  <tr class="tr" xmlns="">
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Intraperitoneal, acute</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Swiss mouse</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">10–200 mg/kg (100 mg/kg)</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">TST</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Reduced immobility time</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td"> </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DR+</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">[ 
    <xref rid="B59-molecules-22-01290" ref-type="bibr" class="xref">59</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Controls: negative and positive (imipramine)</td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">
    <inline-graphic xlink:href="molecules-22-01290-i013.jpg" class="inline-graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/>
   </td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Oral gavage, 3 weeks</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">ICR mouse</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">15–30 mg/kg (15 mg/kg)</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">CUMS, FST, TST</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Reversed the decrease of sucrose consumption, the hypolocomotion and the increased immobile time in the TST and FST in CUMS mice</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Restored the CUMS-induced reductions in hippocampal NE and 5-HT levels; Reverted the increased hippocampal pro-inflammatory cytokines levels (IL-1β, IL-6, and TNFα) in CUMS mice; 
    <break class="break"/>Inhibited the increased hippocampal nod-like receptor protein 3 (NLRP3) inflammasome, and caspase-1 protein expression in CUMS mice 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DR+</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[ 
    <xref rid="B72-molecules-22-01290" ref-type="bibr" class="xref">72</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Menthone</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Controls: negative and positive (fluoxetine)</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td"> </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">
    <inline-graphic xlink:href="molecules-22-01290-i014.jpg" class="inline-graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/>
   </td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Oral gavage, acute</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Wistar rats</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">1.0–10.0 µl/mL/kg (1.0 µl/mL/kg)</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">FST</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Reduced immobility time</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td"> </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DR+</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[ 
    <xref rid="B50-molecules-22-01290" ref-type="bibr" class="xref">50</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Methyl-eugenol</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Controls: negative</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td"> </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">
    <inline-graphic xlink:href="molecules-22-01290-i015.jpg" class="inline-graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/>
   </td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Intraperitoneal, three times within 24 h</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">ICR mouse</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">100 mg/kg</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">FST</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">No effects</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td"> </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DR−</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[ 
    <xref rid="B40-molecules-22-01290" ref-type="bibr" class="xref">40</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">α-Pinene</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Controls: negative and positive (imipramine)</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td"> </td>
  </tr>
  <tr class="tr" xmlns="">
   <td rowspan="5" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">
    <inline-graphic xlink:href="molecules-22-01290-i016.jpg" class="inline-graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/>
    <break class="break"/>β-Pinene 
   </td>
   <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Intraperitoneal, three times within 24 h</td>
   <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">ICR mouse</td>
   <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">54.8–173.2 mg/kg (100 mg/kg)</td>
   <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">FST</td>
   <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Reduced immobility time</td>
   <td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td"> </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DR+</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[ 
    <xref rid="B40-molecules-22-01290" ref-type="bibr" class="xref">40</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Controls: negative and positive (imipramine)</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td"> </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">The treatment reduced the spontaneous locomotion</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td"> </td>
  </tr>
  <tr class="tr" xmlns="">
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Intraperitoneal, three times within 24 h</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">ICR mouse</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">100 mg/kg</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">FST</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Reduced immobility time</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">The pretreatment with WAY100,635 (5-HT 
    <sub class="sub">1A</sub> antagonist), propranolol (β-antagonist), DSP-4 (NE neurotoxin), SCH23390 (D 
    <sub class="sub">1</sub> antagonist) prevented the anti-immobility effect 
   </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DR−</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">[ 
    <xref rid="B58-molecules-22-01290" ref-type="bibr" class="xref">58</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Controls: negative and positive (imipramine)</td>
  </tr>
  <tr class="tr" xmlns="">
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">
    <inline-graphic xlink:href="molecules-22-01290-i017.jpg" class="inline-graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/>
   </td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Oral gavage, 7 days</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">ICR mouse</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">60–120 mg/kg (60 mg/kg)</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">LPS-induced depressant-like behavior, FST and TST</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Reversed increased in immobility time in the FST and TST in LPS-treated mice</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Reversed the reduced concentrations of 5-HT and NE, and attenuated LPS-induced increases of serum protein levels and prefrontal cortex mRNA of TNF-α and IL-6</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DR+</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[ 
    <xref rid="B70-molecules-22-01290" ref-type="bibr" class="xref">70</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Controls: negative and positive (fluoxetine)</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td"> </td>
  </tr>
  <tr class="tr" xmlns="">
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Perillaldehyde</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Inhalation, 9 days</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">ddY mouse</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">0.1–10% dropped on the area between eyes and nose (1%)</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">CUMS, FST</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Reduced immobility time in naïve mouse and reversed increased immobility time in CUMS mice</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td"> </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DR+</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[ 
    <xref rid="B57-molecules-22-01290" ref-type="bibr" class="xref">57</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Controls: negative and positive (minalcipran)</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td"> </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">
    <inline-graphic xlink:href="molecules-22-01290-i018.jpg" class="inline-graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/>
   </td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Oral gavage, once daily, 15 days</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Wistar rat</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">10 mg/kg</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">FST</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Restored increased immobility time in rats subjected to a model of neuropathic pain</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td"> </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DR−</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[ 
    <xref rid="B46-molecules-22-01290" ref-type="bibr" class="xref">46</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">α-Phellandrene</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Controls: negative and positive (ketamine)</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td"> </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">
    <inline-graphic xlink:href="molecules-22-01290-i019.jpg" class="inline-graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/>
   </td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Oral gavage, 3 weeks</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">ICR mouse</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">15–30 mg/kg (15 mg/kg)</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">CUMS, TST, FST</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Reversed the decrease of sucrose consumption, the loss of body weight, and the increased immobile time in the TST and FST in CUMS mice</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Restored the CUMS-induced reductions in hippocampal NE and 5-HT; Reverted the increased hippocampal mRNA of pro-inflammatory cytokines (IL-1β, IL-6, and TNFα) in CUMS mice; Inhibited the activation of nod-like receptor protein 3 (NLRP3) inflammasome and its adaptor, and subsequently decreased the expression of caspase-1</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DR+</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[ 
    <xref rid="B73-molecules-22-01290" ref-type="bibr" class="xref">73</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Thymol</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Controls: negative and positive (fluoxetine)</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td"> </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">
    <inline-graphic xlink:href="molecules-22-01290-i020.jpg" class="inline-graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/>
   </td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Intraperitoneal, acute</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Swiss mouse</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">20 mg/kg</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">FST, TST</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Reduced immobility time in both tests</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">A significant elevation of 5-HT whole brain levels was observed; Increased glutathione levels and decreased TBARS levels in the whole brain</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DR−</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[ 
    <xref rid="B74-molecules-22-01290" ref-type="bibr" class="xref">74</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Thymoquinone</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Controls: negative and positive (fluoxetine)</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td"> </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">
    <inline-graphic xlink:href="molecules-22-01290-i021.jpg" class="inline-graphic" xmlns:xlink="http://www.w3.org/1999/xlink"/>
   </td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Oral gavage, acute and 10 days</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Swiss mouse (male and female)</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">10–100 mg/kg (10 mg/kg)</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">FST, TST</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td">Reduced immobility time under acute and chronic treatments</td>
   <td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1" class="td"> </td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">DR+</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">[ 
    <xref rid="B75-molecules-22-01290" ref-type="bibr" class="xref">75</xref>] 
   </td>
  </tr>
  <tr class="tr" xmlns="">
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Vanillin</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td">Controls: negative and positive (fluoxetine and imipramine)</td>
   <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1" class="td"> </td>
  </tr>
 </tbody>
 <tfoot>
  <p charset="fn" class="fn">
   <p class="p" xmlns="">FST: forced swimming test; TST: tail suspension test; OFT: open field test; CUMS: Chronic unpredictable mild stress; DR+: dose/concentration response design; DR−-: absence of dose/concentration response; 5-HT: serotonin; DA: dopamine; NE: noradrenaline.</p>
  </p>
 </tfoot>
</table>
